Simone Filosto
5PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 06, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia.Naval Daver, James S Blachly, Armin Ghobadi
|Jul 07, 2025
Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma.Assia Hijazi, Frederick L Locke, Nathalie Scholler
|Nov 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).Simone Filosto, Saran Vardhanabhuti, Miguel A Canales
|Aug 01, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11.Michael D Jain, David B Miklos, Caron A Jacobson
|Mar 31, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.Jason R Westin, Frederick L Locke, Michael Dickinson
Pageof 1
Frequent Collaborators
3 joint publications
Christina To
2 joint publications
Jason R Westin
2 joint publications
Frederick L Locke
2 joint publications
Armin Ghobadi
2 joint publications
Paul Cheng
2 joint publications
David B Miklos
2 joint publications
Tan Trinh
2 joint publications
Jennifer Sun
2 joint publications
Saran Vardhanabhuti
2 joint publications
Caron A Jacobson
